MIM
ALAB icon

MetLife Investment Management’s Astera Labs ALAB Stock Holding History

MetLife Investment Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$870K Sell
7,938
-198
-2% -$28.2K ﹤0.01% 1464
2025
Q4 		$1.35M Buy
8,136
+70
+0.9% +$11.7K 0.01% 1268
2025
Q3 		$1.58M Sell
8,066
-838
-9% -$138K 0.01% 1219
2025
Q2 		$805K Buy
8,904
+6,681
+301% +$528K ﹤0.01% 1427
2025
Q1 		$133K Buy
2,223
+86
+4% +$7.96K ﹤0.01% 2398
2024
Q4 		$283K Buy
2,137
+1,702
+391% +$160K ﹤0.01% 2113
2024
Q3 		$22.8K Sell
435
-9
-2% -$422 ﹤0.01% 2816
2024
Q2 		$26.9K Buy
+444
New +$30.8K ﹤0.01% 2858

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

MetLife Investment Management's ALAB Position: Q1 2026 in Review

MetLife Investment Management reduced its Astera Labs (ALAB) stake by 2.4% in Q1 2026, selling an estimated $28.2K and leaving 7,938 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

MetLife Investment Management first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.58M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • MetLife Investment Management held 7,938 shares of Astera Labs worth $870K as of Q1 2026.
  • MetLife Investment Management sold 198 Astera Labs shares in Q1 2026, an estimated $28.2K.
  • Astera Labs made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1464 holding.
  • MetLife Investment Management first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • MetLife Investment Management's Astera Labs position peaked at $1.58M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.